Asia’s cell and gene therapy industry is investing in long-term global opportunities, especially in CAR-T, CAR-NK, Stem cell and iPSC-based cell therapies, CRISPR-based gene therapies, genome-editing technologies and many more.  Likewise, global investors and partners are keen on...

While China, India, and Korea are leading the pack in the Asia region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector and capture a share of the global market. The 2009 national plan for biotech development helped kick-start the sector,...

The 2021 Taiwan Regenerative Medicine Symposium is held on August 17^th, 2021. During the symposium, leaders of regenerative medicine in Taiwan will provide a comprehensive look at the work of regenerative medicine done in Taiwan that offers promise for further local and...